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Post traumatic stress disorder
ACH-000029
A B S T R A C T
Post-traumatic stress disorder (PTSD) is a mental health condition that is triggered by a stressful event, with
symptoms including exaggerated startle response, intrusive traumatic memories and nightmares. The single
prolonged stress (SPS) is a multimodal stress protocol that comprises a sequential exposure to physical restraint,
forced swimming, predator scent and ether anesthesia. This procedure generates behavioral and neurobiological
alterations that resemble clinical findings of PTSD, and thus it is commonly used to model the disease in rodents.
Here, we applied c-fos mapping to produce a comprehensive view of stress-activated brain regions in mice
exposed to SPS alone or to SPS after oral pretreatment with the serotonin-noradrenaline receptor dual modulator
ACH-000029 or the α1-adrenergic blocker prazosin. The SPS protocol evoked c-fos expression in several brain
regions that control the stress-anxiety response, including the central and medial amygdala, the bed nucleus of
the stria terminalis, the pallidum, the paraventricular hypothalamus, the intermediodorsal, paraventricular and
central medial thalamic nuclei, the periaqueductal gray, the lateral habenula and the cuneiform nucleus. These
effects were partially blocked by pretreatment with prazosin but completely prevented by ACH-000029.
Collectively, these findings contribute to the brain-wide characterization of neural circuits involved in PTSD-
related stress responses. Furthermore, the identification of brain areas regulated by ACH-000029 and prazosin
revealed regions in which SPS-induced activation may depend on the combined or isolated action of the nor-
adrenergic and serotonergic systems. Finally, the dual regulation of serotonin and α1 receptors by ACH-000029
might represent a potential pharmacotherapy that can be applied in the peri-trauma or early post-trauma period
to mitigate the development of symptoms in PTSD patients.
1. Introduction
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric
condition defined by a persistent and amplified emotional response to
past traumatic experiences. PTSD symptoms are comprised of intrusive
thoughts, avoiding reminders, sleep disturbance and increased arousal
(American Psychiatric Association, 2013). Although some patients
benefit from the available pharmacotherapy, most experience only
temporary and limited suppression of their symptoms after treatment
(Bernardy and Friedman, 2015; Starke and Stein, 2017).
Animal models have been used to study the development of PTSD-
like symptoms after a traumatic event (Flandreau and Toth, 2018).
These models usually involve exposure of the animal to a severe, un-
predictable, and inescapable stressor to avoid habituation and mimic
the life-threatening trauma suffered by patients. Most models utilize
physical and psychological stressors such as single prolonged stress
(SPS), predator scent stress, immobilization stress, unpredictable vari-
able stress and social defeat stress to mimic this condition (Borghans
and Homberg, 2015; Deslauriers et al., 2018). Animals subjected to
these models exhibit behavioral alterations such as anxiety-like or fear-
related avoidance behavior and neurobiological changes, including
glucocorticoid receptor (GR) hypersensitivity and amygdala hyper-
activity (Aspesi and Pinna, 2019). The SPS protocol, for example, uses
multiple stressors to induce a broad range of PTSD-related behavioral
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and molecular changes (Liberzon et al., 1999; Perrine et al., 2016;
Souza et al., 2017). Many phenotypes appear only after a 1-week
period, offering a time window for the study of PTSD pathogenesis
(Lisieski et al., 2018; Deslauriers et al., 2018).
Previous work using the above-described models has shown that
molecular changes, including alterations in the serotonin (5-HT) and
noradrenergic (NE) neurotransmitter systems (Krystal and Neumeister,
2009; Hendrickson and Raskind, 2016), are associated with PTSD. In
the SPS model, 5-HT1A and 5-HT2A receptors, which regulate anxiety
levels, show increased expression in the dorsal raphe nucleus and the
hippocampus (Luo et al., 2011; Xiang et al., 2019). In addition, in this
model, 5-HT1A activity is related to neuronal apoptosis of the amygdala
(Liu et al., 2011) and to GR expression in the hypothalamus (Wang
et al., 2009), and pretreatment with a 5-HT1A antagonist partially in-
hibits these alterations. Similarly, α1 and α2-adrenergic receptors play
a role in the increased startle response, aggressive behavior, and social
interaction deficits seen in fear conditioning (Olson et al., 2011), pre-
dator stress (Rajbhandari et al., 2015) and SPS (Toledano et al., 2013)
models.
During our exploration of the interaction between the 5-HT and NE
systems, we have discovered a novel compound, ACH-000029, that
modulates the activity of specific 5-HT and α1-adrenergic receptors.
This compound acts as a nanomolar potent partial agonist of 5-HT1A/D
receptors and as an antagonist of 5-HT2A and α1-adrenergic receptors,
and does not show any relevant activity on other 5-HT and nora-
drenergic receptors, as well as on GABAergic, glutamatergic, dopami-
nergic and histaminergic receptors (Azevedo et al., 2019). ACH-000029
was also shown to exhibit high blood-brain barrier permeation in mice
and acute anxiolytic effects in oral doses ranging from 16 to 30 mg/kg
(Azevedo et al., 2019). In addition, the 7-day treatment with ACH-
000029 after the SPS procedure ameliorated the SPS-induced sociability
impairment and anxiety-like behavior, and modulated c-fos changes in
brain regions involved in anxiety response, like the globus pallidus,
lateral septum, cerebellum, retrosplenial cortex and ventromedial hy-
pothalamus (Azevedo et al., 2020).
In this study, we examined the brain-wide distribution of c-fos in
mice pretreated with vehicle, ACH-000029 or prazosin, and subjected
to the SPS or Sham protocols. The analysis of immediate-early genes
(IEGs) such as c-fos, Egr1 and arc as surrogate markers of neural ac-
tivity is relevant to gain insights into psychiatric disorders and the ac-
tion of drugs in the brain (Gallo et al., 2018). Thus, new studies as-
sessing IEG expression patterns may help to unravel the molecular
mechanisms by which drugs affect behavior in PTSD animal models (De
Bartolomeis et al., 2017). The α1-adrenergic blocker prazosin was in-
cluded as a comparator because it is used off-label to treat anxiety and
nightmares in established PTSD (De Berardis et al., 2015; Khachatryan
et al., 2016). Some authors have also discussed the potential of using
prazosin and other drugs as prophylactic or early treatments in the
prevention of PTSD by limiting the stress experience or interfering with
the consolidation of the traumatic memory in patients who visit an
emergency department after trauma (Green, 2014; Roque, 2015;
Burbiel, 2015; Linares et al., 2017; ClinicalTrials.gov identifier
NCT03045016). This could be also the case for patients diagnosed with
acute stress disorder (ASD), which is characterized by acute stress re-
actions, like intrusion, dissociation, negative mood, avoidance, and
arousal, that may occur in the initial month after a traumatic event
(Bryant, 2018).
2. Materials and methods
2.1. Drugs
Prazosin was purchased from Sigma-Aldrich (St. Louis, MO, USA),
and ACH-000029 was synthesized at Aché Laboratórios (Guarulhos, SP,
Brazil). The compounds were dissolved in distilled water containing
0.2% hydroxypropyl methylcellulose (vehicle). The doses of ACH-
000029 and prazosin used in this study were selected based on the
previous literature (Azevedo et al., 2019, 2020; Knauber and Müller,
2000; Stone and Zhang, 1995). The drugs were administered per oral
(p.o.) by gavage.
2.2. Animals
Male C57BL/6 mice (8–10 weeks of age) were obtained from the
Cold Spring Harbor Laboratory (CSHL). The animals were housed in
pairs at room temperature of 23 ± 2 °C, relative humidity of
60 ± 10% and artificial lighting between 7:00 and 19:00. Food and
water were available ad libitum. The animals were maintained in ac-
cordance with the Animal Welfare Act and the Department of Health
and Human Services Guide for the Care and Use of Laboratory Animals.
CSHL's animal facility is accredited by the American Association for
Accreditation of Laboratory Animal Care. The animal procedures used
in this study were approved by the CSHL's ethics committee (number
933272-15).
2.3. Single prolonged stress protocol (SPS)
The SPS protocol was conducted as described in Perrine et al. (2016)
and Malikowska et al. (2017). Each mouse was restrained for 1 h in a
BD Falcon© 50-mL conical tube with a screw-on top and air holes lo-
cated 1/2 cm apart; following the restraint, the animals underwent a
20-min group swim session (n = 4–8 mice per swim) in a 4-L beaker
(diameter = 18.4 cm) filled with water to a depth of ~25 cm (3.5 L) at
room temperature (~23 °C). The animals were then towel dried and
returned to their original cages, where they were exposed for 15 min to
the predator cue using soiled bedding from the cages of sentinel rats.
The mice were then exposed to increasing concentrations of diethyl
ether until they lost consciousness. Diethyl ether-soaked cotton balls
were added at 1-min intervals to minimize the rapid onset of loss of
consciousness. Sham animals were handled and allowed to explore an
empty 4-L beaker for a period equivalent to the duration of the pro-
tocol. Previous studies have shown that increased c-fos expression is
observed for at least 2–3 h after the novel context exposure
(VanElzakker et al., 2008; Bisler et al., 2002). At the end of the pro-
tocol, the animals were placed in new cages with fresh bedding and
returned to the vivarium.
2.4. Experimental protocol and groups
Mice (n = 10 per group) were randomized into (i) Vehicle-Sham,
(ii) Vehicle-SPS, (iii) ACH-000029-SPS and (iv) Prazosin-SPS groups.
The animals were pretreated with vehicle, ACH-000029 (30 mg/kg
p.o.) or prazosin (10 mg/kg p.o.) 30 min before the SPS or Sham pro-
tocol was initiated. Brain c-fos expression was analyzed 60 min after the
end of the SPS protocol and was performed blind to the treatment
groups. The c-fos expression was assessed at this timepoint to capture c-
fos induction derived from all steps of the stress procedure, which is in
line with other studies that analyzed c-fos expression 60 min after the
stress period (Lin et al., 2018; Martinez et al., 2002; Hoffman et al.,
1993). The animals were anesthetized with ketamine/xylazine and sa-
crificed by transcardial perfusion with saline and 4% formaldehyde,
and their brains were dissected and post-fixed.
2.5. Brain-wide c-fos expression analysis
Neuronal activation in the mouse brain was mapped at single-cell
resolution using the same brain-wide c-fos immunohistochemistry
procedure described elsewhere (Osten and Margrie, 2013; Renier et al.,
2016), which evaluates more than 800 anatomical regions of interest
(ROIs) from the Allen Mouse Brain Atlas. Samples were imaged in sa-
gittal orientation (right lateral side up) using light-sheet fluorescence
microscopy (Ultramicroscope II, LaVision Biotec, Bielefeld, Germany).
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The c-fos positive (c-fos+) neurons were identified by convolutional
neural networks and visualized in 3D, as described in Kim et al. (2015).
The CN configuration included 3 hidden layers. The data set was di-
vided into 6 folds and five CNs were trained with each training set. Of
the five CNs, the CN with maximum F-score on its test data was se-
lected. The CN training was performed using the Cortical network si-
mulator (Mutch et al., 2010). The datasets were warped in 3D by affine
and B-spline transformation to an average reference mouse brain gen-
erated from the brains of forty 8-week-old C57BL/6 mice (Kim et al.,
2015, 2016). The data are reported as bar graph representations or
anatomical visualizations in which neuronal activation is represented
by an increase in c-fos+ cells and visualized as a “red” signal. Analo-
gously, neuronal inhibition is represented by a decrease in c-fos + cells
and is visualized as a “green” signal overlaid on a grayscale image of the
mouse brain. Selected ROIs were drawn as dashed white lines in the
images.
2.6. Statistical data analysis
Statistical comparisons between the groups were made based on the
ROIs as described in details elsewhere (Kim et al., 2015, 2016). The cell
counts at a given location, Y, were assumed to follow a negative bi-
nomial distribution the mean of which is linearly related to one or more
of the experimental conditions, X: E[Y] = α+βX. For example, when
comparing an experimental group with a control group, X is a single
column showing the categorical classification of the sample according
to its group id, i.e., 0 for the control group and 1 for the experimental
group. The maximum likelihood coefficients α and β were found
through an iterative reweighted least squares method, obtaining esti-
mates for sample standard deviations and estimates of significance for
the β coefficient. A significant β indicates that the group status is re-
lated to the cell count intensity at the specified location. Z-values were
calculated based on the β coefficient normalized by its standard de-
viation, which under the null hypothesis of no group effect has an
asymptotic standard normal distribution. The p-value is the probability
of finding a β coefficient as extreme as the one seen by chance if the null
hypothesis is true. To account for multiple comparisons across all ROI
locations, the p-values were thresholded at a false discovery rate (FDR)
of 5% (q-value) using the Benjamini-Hochberg (BH) procedure
(Benjamini and Hochberg, 1995). The BH procedure compares each
original (uncorrected) p-value to its critical value, (i/m) *Q, where i is
the rank of the individual p-value in ascending order, m is the total
number of tests, and Q is the FDR. The largest p-value with p < (i/m)
*Q is considered to be the significance threshold. Scatter plots were also
built to compare the z-scores of each brain region between the SPS-
vehicle versus Sham-vehicle comparison (x-axis) and the ACH-000029
or prazosin-treated groups (y-axis). The graph elements represent the
brain regions and were illustrated with green or red colors when z-
scores were less than −2 (downregulated) or larger than +2 (upre-
gulated), respectively.
3. Results and discussion
3.1. Brain-wide c-fos mapping of regions activated and deactivated by the
SPS protocol
The comparative analysis of c-fos expression in the brains of animals
from the Vehicle-SPS and Vehicle-Sham groups disclosed regions that
are regulated by the SPS procedure. Table S1 lists all brain regions that
showed differences in c-fos expression between the Vehicle-SPS and
Vehicle-Sham groups. In Fig. 1, the differences in c-fos + cell counts
between these groups are also shown for selected brain regions in the
cerebral cortex, bed nucleus of the stria terminalis (BST), amygdala,
thalamus, hypothalamus, hindbrain and midbrain. There was a large
increase of c-fos+ cells in stress-related brain areas in the SPS group,
such as in the prefrontal cortex, nucleus accumbens (ACB), BST, central
amygdala (CEA), medial amygdala (MEA), midline thalamic nuclei,
hypothalamic nuclei, brainstem and hindbrain - including the peria-
queductal gray (PAG), parabrachial nucleus (PB), and raphe nuclei
(Adhikari, 2014).
In the cerebral cortex (Fig. 1A and Table S1), brain activation (in-
creased numbers of c-fos+ cells) and inactivation (decreased numbers
of c-fos+ cells) were seen in various cortical areas in the Vehicle-SPS
group. The most pronounced activation patterns were observed in the
deep layers of the primary and secondary somatosensory cortex (SSp
and SSs, respectively) and the posterior and ventral auditory cortex
(AUDp and AUDv). Cortical inactivation across multiple cortical areas
was also observed, with the most pronounced effect seen in the piriform
cortex (PIR) and the olfactory tubercle (OT), the dorsal agranular in-
sular cortex (AId), the ventral agranular insular cortex (AIv), the su-
perficial layers of the SSp, and the superficial and middle layers of the
primary visual cortex (VISp). Other areas in which inactivation was
observed included the ventral and dorsal retrosplenial cortices (RSPv
and RSPd), the ventrolateral area (ORBvl) and the ventral part of the
anterior cingulate cortex (ACAv).
The cortical patterns seen in the Vehicle-SPS versus Vehicle-Sham
comparison likely reflect the differences in the protocols to which these
two groups were subjected. The first group was subjected to acute stress
brought on by restraint, forced swimming, exposure to soiled bedding
and ether anesthesia, while the second group was allowed to freely
explore the novel context of a dry glass beaker and then placed in new
clean cages. Thus, the inactivation patterns seen in the visual cortex,
piriform cortex, and many associational areas of mice subjected to the
SPS protocol - i.e. lower c-fos+ cell counts in the Vehicle-SPS versus the
Vehicle-Sham group - may reflect either the different contextual ex-
periences between these groups or the suppressive effect of SPS in these
regions. In line with this conclusion, animals exposed to a single severe
stressor or to chronic stress have c-fos levels lower than controls in
some areas of the brain (Vallès et al., 2006; Knox et al., 2016; Moench
et al., 2019), suggesting that enduring traumas could induce an adap-
tive response in the corticolimbic system.
The hippocampal formation (Fig. 1A and Table S1) primarily
showed patterns of inactivation in the dorsal parts of the CA1, CA2 and
CA3 fields, the dentate gyrus (DG) and the dorsal subiculum (SUBd),
presubiculum (PRE) and postsubiculum (POST). Conversely, relatively
minor activation was detected in the ventral subiculum (SUBv) and the
adjacent medioventral entorhinal cortex (ENTmv). The predominant
inactivation in the hippocampus, which was shown by the presence of
more c-fos+ cells in the Sham group, likely reflects the above-men-
tioned exploration of the novel environment by these animals, as this
type of spatially oriented activity is known to engage these brain
structures.
In the dorsal part of the striatum, the caudoputamen (CP) did not
show major differences in c-fos expression in the Vehicle-SPS and
Vehicle-Sham groups. In the ventral part of the striatum, the ACB was
activated rostrally in the SPS group. This field represented the ventral
continuation of the c-fos activation in the caudal prelimbic (PL) and ILA
(infralimbic) regions, neighboring the activation in the rostral part of
the lateral septum (LSr), and continued caudally into a robust activa-
tion of essentially all BST nuclei (Fig. 1B, Table S1). Finally, both the
central amygdala (CEA) and the medial amygdala (MEA) displayed
robust c-fos activation in the SPS group. There was also a trend of in-
creased c-fos expression in the basolateral (BLA, q-value = 0.060) and
basomedial (BMA) amygdala (q = 0.078) in the SPS group. These
patterns, especially in the ACB, BST, CEA and MEA, are consistent with
the role of these structures in the brain stress-anxiety response and
related psychiatric disorders (Lebow and Chen, 2016).
In the thalamus (Fig. 1C), the comparison of the Vehicle-SPS and the
Vehicle-Sham groups revealed activation of the medial thalamic nuclei,
including the medial group of the dorsal thalamus (MED), the inter-
mediodorsal nucleus of the thalamus (IMD), the mediodorsal nucleus of
the thalamus (MD), the submedial nucleus of the thalamus (SMT), the
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midline group of the dorsal thalamus (MTN), including the para-
ventricular nucleus (PVT), and the intralaminar nuclei of the dorsal
thalamus (ILM), including the rhomboid nucleus (RH), the central
medial nucleus (CM), and the parafascicular nucleus (PF). These nuclei
are part of the “limbic thalamus”, which predominantly connects with
limbic-related structures such as the amygdala and the nucleus ac-
cumbens and plays a role in affective behavior and drug-seeking ac-
tivity (Vertes et al., 2015).
The SPS protocol induced a robust activation across the hypotha-
lamus (Fig. 1C), which is a crucial area for the stress response mediated
by the hypothalamo-pituitary-adrenal (HPA) system. The activated
hypothalamic structures and the BST and CEA of the basal nuclei, which
lie upstream to the hypothalamus in the stress response, connect
densely with the paraventricular nucleus of the hypothalamus (PVH),
which is an integrative structure of the HPA axis (Herman et al., 2016).
The PVH also sends connections to midbrain and hindbrain nuclei that
monitor changes in different systems of the body and provide upstream
feedback; these nuclei were also activated by exposure of the animals to
the SPS protocol.
The midbrain and hindbrain (Fig. 1D) also exhibited activation of
stress-anxiety nodes. For example, the SPS protocol induced massive
activation rostrocaudally in the PAG, most of the PB divisions, the
central linear raphe nucleus (CLI), the dorsal raphe nucleus (DR) and in
the locus coeruleus (LC). The activated region in the rostral PAG
overlaps with the region that responds physiologically to stressors such
as radiant heat and exposure to predators (Comoli et al., 2003). In
Fig. 1. Brain-wide c-fos mapping of regions regulated by the single prolonged stress (SPS) protocol in mice. Differences in c-fos+ cell counts between the
Vehicle-SPS and Vehicle-Sham groups in selected regions of the cerebral cortex, the bed nucleus of the stria terminalis, the amygdala, the thalamus, the hypotha-
lamus, the hindbrain and the midbrain are shown. *q < 0.05, **q < 0.01, ***q < 0.001. The c-fos expression was analyzed 60 min after the end of the SPS
protocol.
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parallel, the PB nuclei receive massive input from the hypothalamic
nuclei and pain information from the dorsal horn of the spinal cord.
3.2. Brain areas with altered activity in the drug-pretreated and Vehicle-
Sham groups
The comparisons between the ACH-000029-SPS and Vehicle-Sham
groups and the Prazosin-SPS and Vehicle-Sham groups were performed
to evaluate how far the brain activation patterns in mice pretreated
with the test substances and subjected to the SPS protocol would be
from a normal state in animals experiencing a novel context. The
analysis was based on the following reasoning: i) if the drug pretreat-
ment entirely mitigated the stress-induced response, the c-fos+ cell
counts in the Sham and the drug-pretreated groups would be similar,
and little difference would be observed in the comparisons; ii) if the
drug had only a partial blocking effect, activation of stress-related
structures would be observed in the drug-treated group, although to a
lesser extent than in the Vehicle-SPS group.
Scatter plots were constructed to show the relationship between the
z-scores for each brain area in the Vehicle-SPS versus Vehicle-Sham and
ACH-000029-SPS (Fig. 2A) or Vehicle-SPS versus Vehicle-Sham and
Prazosin-SPS (Fig. 2B) comparisons. Brain regions that were differen-
tially regulated in the Vehicle-SPS group are displayed as red (up) or
green (down) circles. Interestingly, almost no activation was found in
the ACH-000029-SPS versus Vehicle-Sham comparison, whereas several
stress-related structures were activated in the Prazosin-SPS group
compared to the Vehicle-Sham group. This is illustrated by the much
smaller number of brain structures seen in the upper-right quadrant of
Fig. 2A compared to Fig. 2B.
In the cerebral cortex, the SPS protocol induced the activation of
auditory and somatosensory areas, which was downregulated by pre-
treatment with either ACH-000029 or prazosin (Fig. 3A and B). A de-
crease in c-fos+ cells was seen in frontal cortical areas in both the ACH-
000029-SPS and Prazosin-SPS groups, such as in the ILA and PL regions,
Fig. 2. Differential brain c-fos activation pat-
terns for the comparisons between the drug-
pretreated groups and the Vehicle-Sham group.
(A) Scatter plot showing the relationship between
the z-scores for each brain region in the comparisons
Vehicle-SPS versus Vehicle-Sham (x-axis) and ACH-
000029-SPS versus Vehicle-Sham (y-axis). (B)
Scatter plot showing the relationship between the z-
scores for each brain region in the comparisons
Vehicle-SPS versus Vehicle-Sham (x-axis) and
Prazosin-SPS versus Vehicle-Sham (y-axis). Brain
regions that showed up- or downregulation of c-fos
expression in the Vehicle-SPS group are represented
as red and green circles, respectively. (For inter-
pretation of the references to color in this figure
legend, the reader is referred to the Web version of
this article.)
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anterior cingulate cortex (ACC), piriform cortex, entorhinal area and
cortical amygdala (Fig. 3B and D). Both the dorsal and the ventral
hippocampus also showed inactivation in the groups pretreated with
the test substances (Fig. 3D). This inactivation pattern in the hippo-
campus could be interpreted as a higher neuronal activity in the Sham
group related to free exploration of a novel environment or to the
suppressive effect of SPS in this region.
In the basal nuclei, no significant differences were observed in the
ACH-000029-SPS versus Vehicle-Sham comparison. In contrast, the
Prazosin-SPS versus Vehicle-Sham comparison revealed significant ac-
tivation in the CP, ACB, BST, CEA, and MEA as well as in the lateral
septum (Fig. 3A and B); higher c-fos+ cell counts were observed in
these stress-related structures, showing that prazosin had only a partial
counteracting effect.
In the hypothalamus, ACH-000029 also prevented the stress-evoked
response; there was no significant difference in the number of c-fos
+ cells in the ACH-000029-SPS and Vehicle-Sham groups. In contrast,
the number of c-fos+ cells was increased in the hypothalamus of mice
from the Prazosin-SPS group. An example of the partial blocking effect
of prazosin was also seen in the paraventricular hypothalamic nucleus
(Fig. 3A), including the parvicellular neurons that project to the peri-
aqueductal gray and to the parabrachial nucleus; this nucleus is the
(caption on next page)
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primary driver of HPA responses (Herman and Tasker, 2016).
Likewise, no differences were seen in the thalamic nuclei in the
Sham versus ACH-000029-SPS comparison, although several thalamic
subnuclei were activated in the Prazosin-SPS group, including the
medial, mediodorsal and intermediodorsal thalamic nuclei (Fig. 3C);
this also indicates a partial blocking effect of prazosin. Another struc-
ture that showed a limited blocking effect of prazosin and a more
suppressive effect of ACH-000029 was the lateral habenula (LH) in the
epithalamus (Fig. 3B), a structure devoted to mood regulation and
aversive encoding through modulation of the dopamine and serotonin
systems (Lazaridis et al., 2019).
In the midbrain and hindbrain (Fig. 3E), a similar pattern was seen
in stress-related structures such as the PAG, where there was no dif-
ference between the ACH-000029-SPS and Vehicle-Sham groups but a
statistically significant activation in the Prazosin-SPS versus Vehicle-
Sham comparison. This activation was, however, lower than that ob-
served in the Vehicle-SPS versus Vehicle-Sham comparison (Fig. 3B).
Another example is the cuneiform nucleus (Fig. 3C and D), a reticular
nucleus involved in cardiovascular function and stress (Korte et al.,
1992).
3.3. Brain areas with altered activity in the drug-pretreated and Vehicle-SPS
groups
To further investigate whether the pretreatment with ACH-000029
or prazosin would limit the stress experience and the resulting brain
activation evoked by the SPS protocol, we compared the Vehicle-SPS
group with the ACH-000029-SPS group and with the Prazosin-SPS
group. If the pretreatment with ACH-000029 or prazosin reduced the
SPS-evoked stress response, this would be manifested as a relative in-
hibition of c-fos expression in the animals pretreated with these drugs.
Accordingly, a very broad pattern of inhibition (significantly lower c-
fos+ cell counts) was seen in stress-responsive brain structures in both
the ACH-000029-SPS versus Vehicle-SPS comparison and in the
Prazosin-SPS versus Vehicle-SPS comparison.
Fig. 4A and B show scatter plots indicating the up- and down-
regulated brain regions observed in the comparisons between the drug-
pretreated groups and the Vehicle-SPS group (y-axis) compared to those
observed in the Vehicle-SPS versus Vehicle-Sham (x-axis) comparison.
Brain areas that were upregulated in the Vehicle-SPS versus Vehicle-
Sham animals but downregulated in terms of c-fos+ cell counts in the
comparisons between the drug-pretreated groups and the Vehicle-SPS
group are shown as green circles. Brain regions that were down-
regulated in the Vehicle-SPS versus Vehicle-Sham groups but upregu-
lated in the drug-pretreated groups are displayed as red circles.
ACH-000029 and prazosin mitigated SPS-induced c-fos activation in
several stress-related brain regions, including the bed nucleus of the
stria terminalis (BSTp, BSTpr, BSTtr, BSTmg, and BSTdm), the para-
ventricular hypothalamic nucleus (PVHd, PVHlp, and PVHf) and the
ventral medial nucleus of the thalamus (VM). Only ACH-000029
downregulated c-fos+ cell counts in the intermediodorsal (IMD) and
medial groups (MED) of nuclei in the dorsal thalamus and in the tu-
beromammillary nucleus (TMd). Neither of the drugs prevented c-fos
activation in the arcuate hypothalamic nucleus (ARH) or in the epi-
thalamus (EPI).
The representative brain images shown in Fig. 5A and B show that
the cortical activation in the Vehicle-SPS group (shown in Fig. 3), in-
cluding the activation in the SSp, SSs, AUDp and AUDv areas, was
converted to inactivation by the pretreatment of the animals with either
ACH-000029 or prazosin. Interestingly, the superficial and middle
layers of the primary visual cortex (VISp) were activated in the ACH-
000029-SPS group but not in the Prazosin-SPS group (Fig. 5B), sug-
gesting higher activity in the visual cortex of the ACH-000029-pre-
treated mice. This indicates that the SPS protocol could induce a
blunting effect in cortical sensory areas and ACH-000029-treated ani-
mals would exhibit activation in the visual cortex due to the attenuation
of this stress response. In fact, habituation to repeated restraint stress
was associated with lack of stress-induced c-fos expression in primary
sensory processing areas (Girotti et al., 2006).
Fewer c-fos+ cells were also detected in the temporal association
and cortical amygdalar areas in the mice pre-treated with the test
substances (Fig. 5B). In the hippocampus, significant differences in c-fos
activation between the Vehicle-SPS group and the drug-pretreated
groups were observed in the dorsal hippocampus (Fig. 5B), while the
ventral hippocampus appeared comparably inhibited in the ACH-
000029 and prazosin groups. Because the dorsal hippocampus pri-
marily performs cognitive functions whereas the ventral hippocampus
relates to stress and affective behavior, the results suggest little differ-
ence in the cognitive experiences between the groups (Fanselow and
Dong, 2010).
In the basal nuclei, the modest activation in the rostral CP seen in
the SPS versus Sham comparison was converted into modest inactiva-
tion after administration of either drug, suggesting that this activation
is specific to stress and that it is mitigated by both compounds. In
contrast, only partial blocking of the stress response by prazosin was
observed in the BST, CEA and MEA, whereas the deactivation in these
areas was very pronounced in the ACH-000029-SPS group (Fig. 5A and
D).
In the thalamus (Fig. 5C), the activation of the medial thalamic
nuclei seen in the Vehicle-SPS group was converted to patterns of in-
activation in the Vehicle-SPS versus ACH-000029-SPS and Vehicle-SPS
versus Prazosin-SPS comparisons, with a more pronounced inhibitory
effect in the ACH-000029-treated group. Similarly, the activation across
the entire hypothalamus (Fig. 5C) was mitigated by both ACH-000029
and prazosin; in some regions of the hypothalamus, including the
medial preoptic area (MPO) and the PVT (Fig. 5A), the decrease in the
number of c-fos+ cells was more pronounced with ACH-000029 pre-
treatment. In the stress-related structures in the midbrain and
Fig. 3. Anatomical description of brain regions regulated in the Vehicle-SPS and drug-pretreated groups compared to the Vehicle-Sham group. The data are
reported as bar graph representations (mean + S.E.M.) or anatomical visualizations in which neuronal activation (increase in c-fos+ cell counts) or inhibition
(decrease in c-fos+ cell counts) are visualized, respectively, as red or green signals overlaid on a grayscale image of a mouse brain. (A) SPS induced activation in the
BST, PVH and MPN as well as in the deep layers of the somatosensory cortex (panel SPS). Pretreatment with prazosin only partially reduced the stress-induced
activation in these structures (panel SPS + Prazosin), while the activation was nearly entirely abolished by pretreatment with ACH-000029 (panel SPS + ACH). (B)
Prominent activation evoked by the SPS protocol is seen in the CEA, MEA, LA, PH, PVT, LH, and the deep layers of the AUD (panel SPS). Pretreatment with prazosin
partially reduced the activation in the LH, CEA and PVT, while the activation was almost fully abolished by pretreatment with ACH-000029. Inhibition in the PIR,
BLA and BMA was more pronounced after prazosin pretreatment. (C) SPS induced activation in the CEA, MEA, and HY (hypothalamus), the PVT (paraventricular
nucleus of the thalamus) and the IMD (intermediodorsal nucleus of the thalamus) as well as in the SS. Prazosin partially reduced and ACH-000029 entirely abolished
the stress-induced activation in these structures. (D) SPS-induced activation is seen in the PAG and deep layers of the AUD (panel SPS). Prazosin pretreatment
partially reduced the stress-induced activation in PAG and AUD, while ACH-000029 completely abrogated this activation. Inhibition in the HPF was seen in all
comparisons, while inhibition in the PIR, ENTl, and COA was more intense in mice pretreated with prazosin than in mice pretreated with ACH-000029. (E) Brainstem
activation evoked by the SPS protocol is seen in the PAG and the CUN (cuneiform nucleus). CUN activation was partially reduced by prazosin but nearly entirely
abolished by ACH-000029 pretreatment. ENTm inhibition was prominent in mice treated with prazosin. *q < 0.05, **q < 0.01, ***q < 0.001. Statistical
comparisons were made against the Sham-Vehicle group. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version
of this article.)
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hindbrain, a similar inhibitory effect was also seen in the groups that
were pretreated with the tested drugs; the PAG, PB and DR contained
fewer c-fos+ neurons in both drug-treated groups.
4. Conclusions
In this work, we evaluated the effects of pretreatment with ACH-
000029 or prazosin on brain c-fos activation following SPS exposure in
mice. The study contributes to the literature in three important ways.
First, to our knowledge, it provides for the first time a comprehensive
brain map of c-fos based activation in the SPS model, revealing neural
circuits triggered by the traumatic experience. Second, it describes
areas that are regulated by ACH-0000029 or prazosin, pointing to
specific 5-HT- versus α1-adrenergic-mediated actions in brain struc-
tures implicated in PTSD. Third, it corroborates our previous findings in
which ACH-000029 treatment in the early post-SPS period prevented
the appearance of PTSD-like symptoms in the SPS model (Azevedo
et al., 2020), highlighting its potential use as a pharmacotherapy in the
peri-trauma or early post-trauma period to mitigate the stress response
that leads to PTSD development.
The SPS protocol is a well-established stress paradigm that has been
used to model intense acute stress. Accordingly, some of the brain
structures activated by SPS were already associated with the circuitry
dysfunctions observed in the rodent brain and in PTSD patients (Fenster
et al., 2018); these structures include parts of the medial frontal, dorsal,
and lateral cortices, the hippocampal formation, the basal nuclei, the
amygdala, the hypothalamus, the midbrain and the hindbrain. Previous
studies in which the SPS model was used have shown alterations in c-fos
expression in the ventral and dorsal hippocampus, the basolateral
amygdala, the infralimbic cortex, the periaqueductal gray and the
Fig. 4. Differential brain c-fos activation pattern
obtained through comparisons between the
drug-pretreated groups and the Vehicle-SPS
group. (A) Scatter plot showing the relationship
between the z-scores for each brain region in the
Vehicle-SPS versus Vehicle-Sham (x-axis) and ACH-
000029-SPS versus Vehicle-SPS (y-axis) compar-
isons. (B) Scatter plot showing the relationship be-
tween the z-scores for each brain region in the
Vehicle-SPS versus Vehicle-Sham (x-axis) and
Prazosin-SPS versus Vehicle-SPS (y-axis) compar-
isons. Brain areas upregulated in the Vehicle-SPS
group but downregulated in the drug-pretreated
groups are represented as green circles. Regions
downregulated in the Vehicle-SPS but upregulated
in the drug-pretreated groups are displayed as red
circles. (For interpretation of the references to color
in this figure legend, the reader is referred to the
Web version of this article.)
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midline thalamic nuclei, regions that are critical to fear extinction and
retention and to emotional learning (Knox et al., 2016; Della Valle
et al., 2019).
The main limitation of this study is that the SPS-induced brain ac-
tivation profile was mapped at a short latency after the SPS protocol
using a single marker of neuronal activity (c-fos). Therefore, further
studies should be performed using other time points and other neuronal
activation markers to describe the temporal dynamics of neuro-
transmitters and differentiate the activation of excitatory and inhibitory
cells that occur after acute intense stress.
The SPS-induced effects in several regions previously implicated in
the stress response were partially blocked by prazosin pretreatment but
fully blocked by ACH-000029 pretreatment. Prazosin was shown to
prevent brain c-fos expression in rodents when used prior to stress
challenges such as immobilization stress (Stone and Zhang, 1995) and
reinstatement of alcohol-seeking behavior (Funk et al., 2016). How-
ever, pretreatment with prazosin did not fully inhibit corticotropin-re-
leasing hormone expression after acute stress (Kiss and Aguilera, 2000),
nor did it attenuate c-fos expression in the paraventricular nucleus or
corticosterone secretion after restraint stress (Williams and Morilak,
1997). These results reinforce the evidence that α1-adrenergic signaling
is necessary but not sufficient to elicit an acute stress response in the
brain.
ACH-000029 entirely prevented the SPS-driven c-fos activation in
Fig. 5. Anatomical description of brain regions regulated in the drug-pretreated groups compared to the Vehicle-SPS group. The data are reported as bar
graph representations (mean + S.E.M.) or anatomical visualizations in which neuronal activation (increase in c-fos + cells counts) or inhibition (decrease in c-
fos + cell counts) are visualized, respectively, as red or green signals overlaid on a grayscale image of a mouse brain. (A) The decrease in the number of c-fos + cells
in BST and hypothalamic areas, such as the PVH, MPO, and LPO, was higher in the ACH-000029-SPS group (panel SPS + ACH). This was also true for the piriform
cortex (PIR) and the paraventricular thalamus (PVT). (B) Inhibition in the hippocampal formation (HPF) and the cortical amygdala (COA) was similar, while
inhibition in the PIR, the lateral association cortices (TEA, ECT, PERI) and the periaqueductal gray (PAG) was more pronounced in the ACH-000029-SPS group. (C)
Inhibition in the hypothalamus (HY) and the midline thalamic nuclei (PVT, CM, IAM) was more pronounced in the ACH-000029-SPS group. (D) The number of c-
fos + cells in the central (CEA) and medial amygdala (MEA) was lower in the ACH-000029-SPS group, while inhibition in the BLA was similar in the two groups.
*q < 0.05, **q < 0.01, ***q < 0.001. Statistical comparisons were performed against the Vehicle-SPS group. (For interpretation of the references to color in this
figure legend, the reader is referred to the Web version of this article.)
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areas essential to the stress-anxiety response, such as the bed nuclei of
the stria terminalis, the central and medial amygdala, the pallidum, the
paraventricular hypothalamus, the cuneiform nucleus, the periaque-
ductal gray and thalamic structures including the mediodorsal, inter-
mediodorsal and central medial nuclei. These results collectively in-
dicate that dual regulation of 5-HT and α1-adrenergic-mediated
neurotransmission is essential to block stress-induced responses in the
brain. The lack of significant differences between c-fos+ cell counts
from cortical sensory areas in the ACH-000029-SPS and Vehicle-SPS
groups suggests that ACH-000029 specifically blocked the stress re-
sponse rather than affected sensory areas in the brain. The inhibition of
the stress circuitry during SPS may attenuate the long-term effects of
the trauma, by controlling the stress experience and the resulting brain
activation induced by the SPS protocol.
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